- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.
Oil prices continued their upward climb Thursday, buoyed by Wednesday's landmark OPEC agreement.
Jim Cramer says he prefers Celgene to Gilead, and Walgreens Boots Alliance to Express Scripts.
Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.